Vol 5 (June 30, 2022): Precision Cancer Medicine

Case Report
RET-mutated non-small cell lung cancer treated with pralsetinib: a case series
Alessandro Galletti, Marco Russano, Fabrizio Citarella, Giuseppina Di Fazio, Valentina Santo, Leonardo Brunetti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
20  
(30 June 2022) 
PDF Full Text (1086) Reporting Checklist COI Form Chinese (1475) Open Access Get Permission
Case Report
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale
Fabrizio Citarella, Marco Russano, Giuseppe Perrone, Giuseppina-Rita Di Fazio, Raffaele Giusti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
19  
(30 June 2022) 
PDF Full Text (1535) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Case Report
KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report
Hajime Oi, Kiyotaka Yoh, Shingo Matsumoto, Hiroki Izumi, Yuji Shibata, Tetsuya Sakai, Kaname Nosaki, Yoshitaka Zenke, Koichi Goto
Precision Cancer Medicine  
2022;
5:
18  
(30 June 2022) 
PDF Full Text (3511) Reporting Checklist Peer Review File COI Form Chinese (1016) Open Access Get Permission
Review Article
Current evidence of BRCA mutations in genitourinary and gynecologic tumors: a scoping review
Alain Chebly, Tony Yammine, Elie Rassy, Stergios Boussios, Michele Moschetta, Chantal Farra
Precision Cancer Medicine  
2022;
5:
17  
(30 June 2022) 
PDF Full Text (1518) Reporting Checklist COI Form Chinese (1280) Open Access Get Permission
Review Article
The role of digital and integrative pathology for the detection of translocations: a narrative review
Carlo Beretta, Stefano Ceola, Fabio Pagni, Vincenzo L’Imperio
Precision Cancer Medicine  
2022;
5:
16  
(30 June 2022) 
PDF Full Text (1584) Reporting Checklist COI Form Chinese (565) Open Access Get Permission
Review Article
Drug-related toxicity in breast cancer patients: a new path towards tailored treatment?—a narrative review
Eleonora Lai, Mara Persano, Marco Dubois, Dario Spanu, Clelia Donisi, Marta Pozzari, Giulia Deias, Giorgio Saba, Marco Migliari, Nicole Liscia, Mariele Dessì, Mario Scartozzi, Francesco Atzori
Precision Cancer Medicine  
2022;
5:
15  
(30 June 2022) 
PDF Full Text (3479) Reporting Checklist Peer Review File COI Form Chinese (2042) Open Access Get Permission
Review Article
The past, present, and future of non-metastatic castration-resistant prostate cancer (nmCRPC): a narrative review
Natalia Vidal, Juan Gómez Rivas, Laura Fernández, Jesús Moreno, Javier Puente
Precision Cancer Medicine  
2022;
5:
14  
(30 June 2022) 
PDF Full Text (4223) Reporting Checklist Peer Review File COI Form Chinese (1774) Open Access Get Permission
Review Article
A narrative review of the management of BRAF non-V600E mutated metastatic non-small cell lung cancer
Inas Abuali, Chung-Shien Lee, Nagashree Seetharamu
Precision Cancer Medicine  
2022;
5:
13  
(30 June 2022) 
PDF Full Text (3462) Reporting Checklist COI Form Chinese (447) Open Access Get Permission
Original Article
Prospective and single-blinded evaluation of the multi-cancer Carcimun-test
Andreas Salat, Wieland Voigt, Berthold von und zu Zwerger
Precision Cancer Medicine  
2022;
5:
12  
(30 June 2022) 
PDF Full Text (1996) Reporting Checklist Data Sharing Statement COI Form Chinese (434) Open Access Get Permission
Editorial
From icing to slicing the cake: the new hope of precision medicine for lung cancer
Giuseppe L. Banna, Alfredo Addeo
Precision Cancer Medicine  
2022;
5:
11  
(30 June 2022) 
PDF Full Text (428) COI Form Chinese (229) Open Access Get Permission